Medical Director, Rheumatology Ta

Johnson & Johnson Johnson & Johnson · Pharma · Horsham, PA +1

Medical Director role in Rheumatology TA within US Medical Affairs at Johnson & Johnson. Focuses on developing and executing clinical study programs, contributing to US Medical Affairs strategy, and preparing regulatory submissions for Rheumatology pipeline and approved products. Collaborates cross-functionally with various internal teams and external stakeholders.

What you'd actually do

  1. Develop and execute (as Study Responsible Physician or Scientist [SRP/SRS]) Medical Affairs sponsored clinical study programs, including but not limited to Phase 3b/4 trials, registries, real-world evidence studies, investigator-initiated and/or collaborative studies in the Rheumatology TA. Contribute/lead study design, protocol development, clinical study report and publication development. Work closely with the matrix clinical trial teams and external investigators/KOLs on study operations and provide program leadership and medical oversight.
  2. Contribute to US Rheumatology Medical Affairs strategy, Eg by leading one or more approved and pipeline Rheumatology products/indications Integrated Evidence Teams (IETs), working cross-functionally with partners within the Rheumatology Integrated evidence team (IET), including Medical Science Liaison (MSL) team leaders, RWV&E, Field V&E, SCG, Marketing team brand leads, as well as potentially Rheumatology Disease Area Stronghold (DAS), R&D, Global Medical Affairs and Global Commercial partners to promote and execute the Rheumatology TA Strategy for establishing access as well as plans for and progress and outcomes for evidence generation activities and Data Dissemination Plans.
  3. Contribute to the preparation of regulatory submissions and interactions with Health Authorities (and particularly the FDA

Skills

Required

  • Medical Affairs
  • Clinical study design
  • Protocol development
  • Publication development
  • Regulatory submissions
  • Rheumatology TA
  • Evidence generation
  • Cross-functional collaboration

Nice to have

  • Phase IIIb/IV trials
  • Post-Marketing Requirement studies
  • Investigator-initiated studies
  • Collaborative studies
  • Real-world evidence studies
  • KOL engagement